麻豆传媒

Bernard Weinstein, Ph.D., is an economist and associate director of SMU's Maguire Energy Institute. He is the author or co-author of numerous books, monographs and articles on economic development, public policy and taxation. His expertise has been used on these and energy-related issues in articles published by The New York Times, The Wall Street Journal, The Los Angeles Times and many regional newspapers and magazines.

Raymond L. Woosley, MD, Ph.D., is a Flinn Scholar and professor of Biomedical Informatics and Medicine at the University of Arizona College of Medicine-Phoenix. He is also the founding president and chairman of the Board for AZCERT, Inc., a non-profit organization funded by the U.S. Food and Drug Administration to work with the College of Medicine to improve the safe use of medications.

Dr. Woosley received his medical degree from the University of Miami, FL; his doctorate in pharmacology from the University of Louisville, KY; and his bachelor's degree from Western Kentucky University. After an internship and residency in internal medicine, he completed a fellowship in clinical pharmacology at Vanderbilt University before joining the faculty as founding director of the Vanderbilt Cardiac Arrhythmia Center and rose to the rank of professor of Medicine and Pharmacology and associate director of the Vanderbilt Clinical Research Center.

In 1988, Dr. Woosley was appointed chairman of the Department of Pharmacology at Georgetown University Medical Center in Washington, D.C. He also served as associate dean for Clinical Research and director of the Institute for Cardiovascular Sciences. In 2001, Dr. Woosley joined the faculty at the University of Arizona as vice president of the Arizona Health Sciences Center and the dean of the College of Medicine. In 2005, he founded the Critical Path Institute (C-Path), an independent, non-profit organization created jointly by the U.S. Food and Drug Administration (FDA) and the University of Arizona to help implement the FDA鈥檚 Critical Path Initiative and accelerate the development of new drugs and diagnostics. In 2012, he founded the non-profit AZCERT, Inc.

Dr. Woosley鈥檚 research has been reported in more than 300 peer-reviewed publications and serves as the basis for eleven patents. For his contributions to medicine, Dr. Woosley has received numerous awards and honors from academic institutions, the Food and Drug Administration and professional societies.

Deborah Riebe, Ph.D., obtained her B.S. degree from Springfield College in Physical Education, her M.S. degree from the University of Rhode Island in Exercise Science and her Ph.D. from the University of Connecticut in Exercise Physiology. She is currently Professor and Associate Dean of College of Health Sciences at the University of Rhode Island. Dr. Riebe is a Fellow in the American College of Sports Medicine and served as President of the New England Chapter of American College of Sports Medicine. She is currently the Chair of ACSM’s Committee for Certification and Registry Boards and was recently elected to the Board of Trustees representing education and allied health. Dr. Riebe was recently appointed Senior Editor of the tenth edition of ACSM’s Guidelines for Exercise Testing and Prescription. She has received research funding in the areas of weight management and physical activity promotion from the American Cancer Society, the National Institutes of Health, and the Champlin Foundations. Dr. Riebe has authored over 50 articles in refereed journals and book chapters. Dr. Riebe’s research centers around physical activity interventions for a variety of populations including apparently healthy adults and those with common chronic diseases, older adults, and individuals who are overweight or obese.

Dr. Baron is currently an Associate Professor in the Division of Public Health, Department of Family and Preventive Medicine. She is a clinical psychologist with specialty training in Behavioral Sleep Medicine.

Dr. Baron completed her bachelor's degree with honors and distinction at the Ohio State University. She completed her master's degree and Ph.D. in clinical psychology at the University of Utah. Her predoctoral residency in health psychology was completed at Rush University Medical School. After graduate school, she completed a postdoctoral fellowship in health services research as well as an MPH degree at Northwestern University. Prior to her position at the University of Utah, Dr. Baron held faculty positions at the Feinberg School of Medicine at Northwestern University and Rush University Medical School.

Dr. Baron is involved in sleep research as well as providing non-drug treatment for sleep disorders. In the clinic, she provides Cognitive Behavioral Therapy for Insomnia (CBT-I), the most effective treatment for chronic insomnia. She also delivers cognitive and behavioral treatment for other sleep disorders including circadian disorders, problems using CPAP treatment in sleep apnea, nightmares, sleepwalking, and coping with disorders of excessive sleepiness such as narcolepsy.

Dr. Baron also translates her passion for the science of sleep and sleep disorders treatment as the director of the behavioral sleep medicine training program and is enthusiastic about increasing the training and awareness of non-drug treatments for sleep disorders because they are highly effective at improving sleep and quality of life.

Her research has been supported by the NIH, including the completion of a K23 mentored patient-oriented research award and a current 5 year R01 research project examing the role of sleep and circadian disruption on appetite regulation. Dr. Baron's research has been widely covered by the press including being featured in the press such as the New York Times, Cooking Light, Men's Health, Webmd.com, Wirecutter.com, and US 麻豆传媒 and World Report.

Christine Reilley is the Managing Director of Publishing for the American Society of Mechanical Engineers (ASME), based in New York City. Most recently, she was Managing Director of Strategy and Innovation. Previously, she led the Healthcare Technology Team, which focuses on creating and growing the Society’s portfolio of programs, products, and services in this area. Christine also has served as a program manager in the ASME Emerging Technologies unit, developing content and conferences in areas focusing on bioengineering, nanotechnology, thermofluids, and materials. Previously, she spent more than 10 years in ASME Codes and Standards Publishing as an editor, overseeing the production of codes from manuscript to final bound and digital product.

Mauro F. Guill茅n is the holder of the Zandman Endowed Professorship in International Management at the Wharton School. He served as Director of the Lauder Institute of Management & International Studies between 2007 and 2019. He received a Ph.D. in sociology from Yale University and a Doctorate in political economy from the University of Oviedo in his native Spain.

He is a trustee of the Royal Foundation of Spain, known as the Fundaci贸n Princesa de Asturias, a member of the advisory board of the Escuela de Finanzas Aplicadas (Grupo Analistas), and serves on advisory groups at the World Economic Forum.

He has won the Aspen Institute鈥檚 Faculty Pioneer Award. He is an Elected Fellow of the Sociological Research Association and of the Macro Organizational Behavior Society, a former Guggenheim and Fulbright Fellow and a Member in the Institute for Advanced Study in Princeton. In 2005 he won the IV Fundaci贸n Banco Herrero Prize, awarded annually to the best Spanish social scientist under the age of 40. He has delivered the Clarendon Lectures at Oxford University, the Otto Krause Memorial Lecture at the University of Johannesburg, and the Laurent Picard Distinguished Lecture at McGill University.

He has received a Wharton MBA Core Teaching Award, a Wharton Graduate Association Teaching Award, a Wharton Teaching Commitment and Curricular Innovation Award, the Gulf Publishing Company Best Paper Award of the Academy of Management, the W. Richard Scott Best Paper Award of the American Sociological Association, the Gustavus Myers Center Award for Outstanding Book on Human Rights, and the President鈥檚 Book Award of the Social Science History Association.

His current research deals with the internationalization of the firm, and with the impact of globalization on patterns of organization and on the diffusion of innovations and crises. His most recent books are The Architecture of Collapse: The Global System in the Twenty-First Century (2016), Global Turning Points (2012), and Emerging Markets Rule (2012). He is also the author or co-author of The New Multinationals (2010), Green Products (2011), Building a Global Bank: The Transformation of Banco Santander (2008), The Rise of Spanish Multinationals (2005), The Taylorized Beauty of the Mechanical (2006), The Limits of Convergence: Globalization and Organizational Change in Argentina, South Korea, and Spain (2001), Models of Management (1994), and The AIDS Disaster (1990).

Dr. Licciardone鈥檚 research focuses on the prevention and treatment of chronic pain. He is the first recipient of a Regents Professorship awarded by the Texas College of Osteopathic Medicine since it was established 50 years ago. He also holds the Osteopathic Heritage Foundation Distinguished Chair in Clinical Research in honor of Drs. David Richards and Benjamin Cohen, former President and Provost of the University of North Texas Health Science Center. He presently directs the Osteopathic Research Center, including its PRECISION Pain Research Registry. The latter is the 鈥渇irst-in-the-nation鈥� pain research registry, which studies precision medicine and biopsychosocial approaches to pain management. He received a Midcareer Investigator Award from the National Institutes of Health (NIH), served as an expert panelist for NIH in the area of chronic pain, and completed a four-year term on its National Advisory Council for Complementary and Integrative Health. He directed the OSTEOPATHIC Trial, a five-year study funded by NIH that demonstrated substantial improvements in and recovery from chronic low back pain with osteopathic manipulation. He is presently a Co-Investigator in the $14 million Prevention of Acute to Chronic Back Pain Trial (PACBACK Trial) sponsored by NIH, and recently served on the Work Group that developed NIH鈥檚 Federal Pain Research Strategy. Internationally, Dr. Licciardone has served as a consultant to the World Health Organization on regulatory and safety issues relating to osteopathy in Europe and other nations. He gave the keynote address at Advancing Osteopathy 2008, a conference celebrating the 10th anniversary of recognition of osteopaths in the United Kingdom鈥檚 National Health Service, including a preconference reception with His Royal Highness, The Prince of Wales. He has also met and advised two former United States Surgeons General on the role of osteopathic physicians within the American health care system. The American Osteopathic Foundation has honored Dr. Licciardone with its Gutensohn-Denslow Award for devoted lifetime service and contributions to research and education within the osteopathic profession. 

Roland T. Rust is Distinguished University Professor and David Bruce Smith Chair in Marketing at the Robert H. Smith School of Business at the University of Maryland, where he is founder and Executive Director of the Center for Excellence in Service. He is also Visiting Chair in Marketing Research at Erasmus University (Netherlands) and an International Research Fellow of Oxford University鈥檚 Centre for Corporate Reputation (UK). 

His lifetime achievement honors include the AMA Irwin McGraw-Hill Distinguished Marketing Educator Award, the EMAC Distinguished Marketing Scholar Award, Fellow of the INFORMS Society for Marketing Science, the Paul D. Converse Award, Fellow of the American Statistical Association, as well as the top career honors in service marketing, marketing research, marketing strategy, and advertising, and honorary doctorates in economics from the University of Neuchatel (Switzerland) and the Norwegian School of Economics.  He was one of the inaugural honorees in the American Marketing Association鈥檚 Marketing Legends video series, and one of the inaugural AMA Fellows.  He has won best article awards from five different journals, including four best article awards from the Journal of Marketing, as well as the Berry/AMA Book Award for the best book in marketing.  He served as Editor of the Journal of Marketing, founded the annual Frontiers in Service Conference, was founding Editor of the Journal of Service Research, and served as Editor of the International Journal of Research in Marketing (IJRM). 

He has consulted with many leading companies worldwide, including such companies as American Airlines, AT&T, Comcast, Dow Chemical, DuPont, Eli Lilly, FedEx, Hershey, Hewlett-Packard, IBM, Lockheed Martin, Microsoft, NASA, NCR, Nortel, Procter & Gamble, Sears, Sony, Starwood, Tata, Unilever, and USAA.  A national class distance runner in his collegiate days, he has been inducted into the DePauw University Athletic Hall of Fame. He has coached one age group world champion and several age-group national champions in track and triathlon.  

Shandy Dearth has spent most of her career focusing on infectious disease surveillance, emergency preparedness planning and response, and public health informatics. Prior to joining the FSPH, she was the Director of an international public health association that brought together public health practitioners and public health researchers who focused on health data surveillance projects. Prior to her work with the non-profit, Ms. Dearth was the Administrator in the Epidemiology Department of a local health department. She is currently a member of her community's park advisory council and is a proponent of advocating for more public health resources in Indiana.

Jay Neitz, PhD, is a professor of opthalmology at the University of Washington School of Medicine, and is world-renowned for discovering how to cure color blindness in animals. He also helped discover the gene that causes myopia and is co-founder of a company, SightVision, to make glasses that stop myopia in children. He made these discoveries with his lab partner for life, Maureen Neitz, PhD. Neitz received his Ph.D. from the University of California, Santa Barbara. He studies the biological basis of vision and vision disorders, including color vision. His goal is to make discoveries that will lead to a better understanding of how the visual system and brain work. Dr. Neitz hopes his work will contribute to treatments for vision disorders, including macular degeneration, nearsightedness and colorblindness.

Dr. Benjamin L. Ruddell (Ben), Ph.D., P.E., is a Professor and Director of the School of Informatics, Computing, and Cyber Systems at Northern Arizona University, the President of Ruddell Environmental consulting, the Director of the National Water-Economy Project (NWEP) and the Director of the FEWSion project. His PhD is in Civil and Environmental Engineering from the University of Illinois at Urbana-Champaign. His professional experiences are in the fields of civil engineering, water resources, systems analysis, ecology/ecohydrology, and engineering research and education in an interdisciplinary university setting. He works with a variety of federal, local, and private partners to accomplish cutting-edge projects. His research interests fall broadly in the area of the quantification and management of complex coupled natural-human systems, including regional water and climate systems strongly influenced by the human economy and society- such as in cities, energy, and agriculture. His professional goals are the advancement of the science and management of complex systems, and excellence in education in a university setting.

Matti Kummu is assistant professor at Aalto University, Finland. His research focuses on global water and food issues, particularly assessing the future opportunities towards water-smart food production.

The main focus of his research is the interaction between the human population and water resources. He has been working extensively on assessing the global water scarcity and how it has impacted on food production and availability. To ease the ever-growing pressure on water and land resources, They are working actively in quantifying the potential of different measures, such as diet change, food loss reduction, emerging non-meat protein sources, and yield gap closure, to sustainably increase the food availability globally. Finally, They work also on more local scale challenges and opportunities on water-energy-food nexus, particularly in the Southeast Asian context.

Dr. Larry Corey is an internationally renowned expert in virology, immunology and vaccine development, and the former president and director of the Fred Hutchinson Cancer Research Center in Seattle. For more than four decades, he has led some of the most significant advances in medicine, including the development of safe and effective antivirals for herpes, HIV and hepatitis infections. An international expert in the design and testing of vaccines, he is helping to formulate a global, strategic response to COVID-19.

Earlier this year, he responded to the sudden emergence of COVID-19 by redirecting his energies to speed the development of antiviral medications and vaccines against SARS-CoV-2, the virus responsible for the pandemic. He is building strategic collaborations among academic institutions, government health leaders and the pharmaceutical industry to test future COVID-19 vaccines and find ways to manufacture and distribute enough doses to immunize as many as 4 billion people.

Dr. Corey is drawing on his expertise as a co-founder, in 1998, of the HIV Vaccine Trials Network. Headquartered at Fred Hutch in Seattle, it is the world鈥檚 largest publicly funded collaboration focused on development of vaccines to prevent HIV/AIDS.

Dr. Corey's teaching and mentoring interests include virology, viral immunology and development of novel therapies for viral infections. His current research projects include:

- Spatial and functional characterization of tissue resident immune responses at the site of herpesvirus or HIV infection
- Development of immunotherapies for HSV and HIV infection; including CAR T cells for treatment for HIV infection
- Spatial dynamics and function of adoptively transferred or vaccine induced T cells
- Characterization of tissue-based memory B cells and the role antibody effector responses play in chronic viral infections
- Use of monoclonal antibodies for the prevention of viral infections

In addition to his role as president and director emeritus at Fred Hutch, Dr. Corey is a member of the Center's Vaccine and Infectious Disease, Clinical Research, and Public Health Sciences Divisions.  He is also a Professor, Medicine and Laboratory Medicine at the University of Washington, and Principal Investigator at the HIV Vaccine Trials Network (HVTN). 

Rachel Hess, MD, MS is a Professor of Population Health Sciences and Internal Medicine and the founding Chief of the Division of Health System Innovation and Research (HSIR) program at the University of Utah Schools of the Health Sciences. As a clinician and Health Services Researcher, Dr. Hess brings a unique perspective of translating research into clinical and policy practice. She is the co-principal investigator of one of the original 11 PCORnet Clinical Data Research Networks, PaTH and serves as the co-Director of the Utah CCTS.

Dr. Hess鈥檚 research aims to improve patient-centered outcomes in clinical care. In service of this mission, she seeks to understand the determinants of quality of life, including sexual function, and how the health-related quality of life affects health and cost outcomes. She has conducted cohort studies in midlife women to examine the impact of menopause on health-related quality of life, including sexual functioning. She is currently following a cohort of adults over 50 to characterize the roles of intrapersonal resources, interpersonal relationships, and individual lifestyle in shaping the quality of life across transitions; and the health and healthcare-cost outcomes of quality of life.

Dr. Hess鈥檚 implementation work uses health information technology to engage patients in their care. She has examined the impact of providing patients with guideline-based feedback regarding their health behaviors and health-related quality of life on patient activation and behavior change. Dr. Hess has overseen the development and successful implementation of multiple technology-based programs in primary care. As the director of HSIR, she brings together individuals from across the University of Utah to develop, test, and implement novel approaches that improve health outcomes for the population.

Dr. Hess completed her undergraduate work in mathematics at Washington University, received her medical degree from the University of New Mexico, completed her residency training at Temple University, and completed her general internal medicine and women鈥檚 health fellowships at the University of Pittsburgh.

Thomas N. Denny, MSc, M.Phil, is the Chief Operating Officer of the Duke Human Vaccine Institute (DHVI) and the Center for HIV/AIDS Vaccine Immunology (CHAVI), and a Professor of Medicine in the Department of Medicine at Duke University Medical Center. He is also an Affiliate Member of the Duke Global Health Institute. He has recently been appointed to the Duke University Fuqua School of Business Health Sector Advisory Council. Previously, he was an Associate Professor of Pathology, Laboratory Medicine and Pediatrics, Associate Professor of Preventive Medicine and Community Health and Assistant Dean for Research in Health Policy at the New Jersey Medical School, Newark, New Jersey. He has served on numerous committees for the NIH over the last two decades and currently is the principal investigator of an NIH portfolio in excess of 56 million dollars. Mr. Denny was a 2002-2003 Robert Wood Johnson Foundation Health Policy Fellow at the Institute of Medicine of the National Academies (IOM). As a fellow, he served on the US Senate Health, Education, Labor and Pensions Committee with legislation/policy responsibilities in global AIDS, bioterrorism, clinical trials/human subject protection and vaccine related-issues.

Sheria Robinson-Lane, a gerontologist and assistant professor at the University of Michigan School of Nursing, is an expert in palliative and long-term care and nursing administration. Her research focuses on the care and support of older adults with cognitive and/or functional disabilities, and on ways older adults adapt to changes in health, particularly how adaptive coping strategies affect health outcomes.

Gilberto Montibeller is a Full Professor of Management Science at Loughborough University (UK) and a Senior Research Fellow at the University of Southern California (USA). He joined Loughborough in 2015 after spending a decade as a tenured faculty in the Department of Management at the London School of Economics. He has taken senior management roles at Loughborough University, as Associate Dean for Enterprise and Head of the Management Science and Operations Group.

He has a BSc in Electrical Engineering (UFSC), MSc in Engineering Economic Analysis (UFSC) and PhD in Engineering Economic Analysis (UFSC/Univ. of Strathclyde). After his doctorate, he continued his studies as a pos-doc research fellow in Management Science at the University of Strathclyde.

Prof Montibeller is an expert on strategic risk and decision analysis. His main areas of application are global health prioritisations and health risk management, having led projects for the World Health Organization, Pan-American Health Organization, UK Department for Environment, Health and Rural Affairs (DEFRA), UK Department of Health, the Food and Agriculture Organization of the United Nations (FAO), USAID, among others.

He is Associate Editor of the Informs Decision Analysis journal and has served as area editor of the Journal of Multi-Criteria Decision Analysis. He has published widely in top journals in decision sciences. The quality of his research has been recognised by best publications awards from the Institute for Operations Research and the Management Sciences (Informs), the Society for Risk Analysis, and the International Society on Multi-Criteria Decision Making.

He has been a visiting scholar at the Massachusetts Institute of Technology (MIT), the International Institute for Applied Systems Analysis (IIASA, Austria), and CNRS Lamsade at Paris Dauphine University (France). He is a visiting professor at the University of Sao Paulo (Brazil) and Adjunct Professor at the Hertie School of Government (Germany) and IE Business School (Spain). 

Prof Montibeller has extensive experience with executive education over more than 20 years, having taught courses at the LSE executive schools (UK), LSE corporate education (UK), Warwick Business School (UK), Hertie School of Government (Germany) and IE Business School (Spain).

Dr. Eunice Wang is the Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center. Dr. Wang joined the Roswell Park faculty in 2003 and was appointed to the Leukemia Service of the Department of Medicine. She earned her medical degree from the Keck School of Medicine, University of Southern California and completed residency training in Internal Medicine at Yale-New Haven Hospital, Yale University, New Haven, CT in 1999. From 1999 to 2003, she completed a clinical hematology-oncology and research fellowship at Memorial Sloan Kettering Cancer Center in New York, NY. She is licensed in New York State and is certified by the American Board of Internal Medicine (Internal Medicine 1999; Medical Oncology, 2002; Medical Hematology, 2004). She also is an Assistant Professor, School of Medicine & Biomedical Sciences, University of Buffalo. She is a member of the American Society of Clinical Oncology, American Association for Cancer Research, and American Society of Hematology. Dr. Wang’s clinical research focuses on the development of early stage clinical trials for acute leukemias (AML, ALL) and myeloproliferative disorders. Her translational research interests involve the development of novel biological therapies targeting the bone marrow microenvironment for myeloid malignancies. Dr. Wang has authored/co-authored over 90 peer-reviewed articles, multiple book chapters, and editorials. She is a prior recipient of a NIH Cancer Clinical Investigator Team Leadership Award (CCITLA) in recognition of her contributions to clinical cancer research and a Mentored Research Scholar award from the American Cancer Society. In addition to her research, Dr. Wang maintains an active clinical practice.

Paul J. Thuluvath, M.D., Chief, Division of Gastroenterology at Mercy Medical Center, and Medical Director for The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy leads a top rated physician team of gastroenterology specialists in Baltimore, Maryland, who help patients find the best treatment options for digestive diseases and liver conditions.

As the leader of The Center for Liver and Hepatobiliary Diseases, Dr. Paul Thuluvath provides patients with pioneering treatments and advanced technology to help them manage their illness. He is a recognized national and international authority in liver and biliary diseases and dedicated to medical research and clinical trials that are advancing treatment possibilities for patients. While his patients respect his expertise, they value his bedside concern, empathy and personal care that keeps them encouraged. He welcomes patient questions and family involvement, and is devoted to patient education in the healing process.

Dr. Thuluvath and his team of gastroenterology specialists provide expertise, comprehensive care, advanced facilities for endoscopy procedures and leading edge technology, treatment and pioneering medical research.

Dr. Paul Thuluvath coordinates patient care, when needed, working in collaboration with the specialists of The Institute for Cancer Care at Mercy, The Center for Minimally Invasive Surgery at Mercy, The Center for Interventional Pain Medicine at Mercy, The Lung Center at Mercy, and the Division of Interventional Radiology. This comprehensive approach to diagnosis and treatment of digestive health and liver disease and the expertise of our doctors makes The Institute for Digestive Health and Liver Disease at Mercy a leader in the Mid-Atlantic region.

Authority in Liver and Biliary Diseases

Dr. Paul Thuluvath is a known authority in liver and biliary diseases and pre-and post-liver transplant management. He serves on the Editorial Board for: Hepatology, Liver Transplant, and Gastrointestinal Endoscopy. 

He is a frequent speaker and lecturer at national and international meetings on issues in liver and biliary diseases and has addressed medical groups in China, Germany, India, London, Oman, Philippines, Singapore and the United States.

Dr. Matthew Donahue is a senior lecturer in the Department of Popular Culture at Bowling Green State University, specializing in topics related to popular culture, popular music (rock and roll, punk, heavy metal, reggae, rap/hip-hop, blues, popular music styles from the 1950s to the present), documentary and narrative film, media, visual arts (modern art and popular culture, street photography, art cars), politics and popular culture, travel and tourism and other related topics. He has lectured on such topics regionally, nationally and internationally and has served as an authority on popular culture topics for national and international publications. He is a member of the state of Ohio鈥檚 Ohio Humanities Speakers Bureau, lecturing on topics related popular culture throughout the state of Ohio. Prior to serving as a senior lecturer for the Department of Popular Culture, he served as a supervisor for the Bill Schurk Sound Recordings Archive at Bowling Green State University, working on sound recording reissue projects for Time-Life and Smithsonian.

In addition to his academic work, he is also a musician, artist, filmmaker and writer. As a musician, he has released sound recordings internationally working within a variety of music genres. As a visual artist, he uses popular culture as the basis of his artistic creations, working in two and three-dimensional collage/mixed media, street photography and art cars and has exhibited his work at exhibitions, galleries, festivals and museums throughout the United States. He is an award-winning documentary filmmaker for such films as 鈥淭he Amsterdam T-Shirt Project,鈥� 鈥淭he Hines Farm Blues Club鈥� and 鈥淢otorhead Matters鈥�.  Additionally, he has made documentaries on the history and culture of art cars such as 鈥淭aking It to the Streets: An Art Car Experience鈥� and 鈥淐ar Power: Another Art Car Experience,鈥� as well as music and concert videos related to his various musical projects over the years. His written work consists of the award winning 鈥淚鈥檒l Take You There: An Oral and Photographic History of the Hines Farm Blues Club鈥� and a collection of photography related to his art cars titled 鈥淭aking It to the Streets: An Art Car Experience.鈥� 

He serves as a board member for the Friends of Jerome Library at Bowling Green State University. He also serves on the Editorial Advisory Board for the Metal Music Studies Journal and the Editorial Board for the Media and Popular Culture Journal.   

He has won a variety of awards and accolades related to his academic and creative work.

More information on his academic and creative background can be found on his personal website at www.md1210.com.